Merck (MRK) Price Target Lifted at Morgan Stanley as Biopharma Outlook Improves [Yahoo! Finance]
Morgan Stanley (MS)
Last morgan stanley earnings: 4/16 07:15 am
Check Earnings Report
US:NYSE Investor Relations:
morganstanley.com/about-us-ir
Company Research
Source: Yahoo! Finance
On December 12, Morgan Stanley lifted its price target on Merck & Co., Inc. (NYSE:MRK) to $102 from $100. The firm kept an Equal Weight rating on the stock. In its 2026 outlook for the biopharma space, the firm said many of the policy concerns that weighed on the sector this year are likely to fade, allowing investors to shift their attention back to company fundamentals. Merck & Co., Inc. (NYSE:MRK) has already been gaining momentum, with shares soaring by over 22% over the past six months. A big reason is Keytruda, its oncology drug, which now accounts for roughly half of the company's revenue and has become one of the most important cancer treatments on the market. Its effectiveness and flexibility stand out, with approvals across 20 different cancer types. Beyond Keytruda, Merck has been actively building out its pipeline. The company recently agreed to acquire Cidara Therapeutics for about $9.2 billion in cash. Cidara is developing CD388, a long-acting antiviral aimed at pre
Show less
Read more
Impact Snapshot
Event Time:
MS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MS alerts
High impacting Morgan Stanley news events
Weekly update
A roundup of the hottest topics
MS
News
- How Recent Catalysts Are Shifting the Chevron Narrative for Free Cash Flow and Growth [Yahoo! Finance]Yahoo! Finance
- Bank of America (BAC) Target Cut at Morgan Stanley on Earnings Revisions [Yahoo! Finance]Yahoo! Finance
- Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript [Seeking Alpha]Seeking Alpha
- Shoals (SHLS) Stock Trades Down, Here Is Why [Yahoo! Finance]Yahoo! Finance
- Amgen (AMGN) Price Target Trimmed at Morgan Stanley as Policy Risks Ease [Yahoo! Finance]Yahoo! Finance
MS
Earnings
- 10/16/25 - Beat
MS
Sec Filings
- 12/16/25 - Form 424B2
- 12/16/25 - Form 424B2
- 12/16/25 - Form 424B2
- MS's page on the SEC website